IL1B and neoplasm: The main difference between them two is that antitumor agents act by releasing cytokines that promote adaptive immunity (IL-1, IL-6, TNF-α, NO, etc.)and have a high expression of MCH-2 (major histocompatibility complex 2) molecules, allowing the presentation of tumor antigens to cells of the immune system.